Fund Holdings — Rhenman & Partners Asset Management AB

Total Portfolio Value:
$1.04B
Total Bought:
$205.09M
Total Sold:
$195.81M
Net Transaction:
+$9.29M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
UnitedHealth Group Incorporated(UNH)40,500105,300+64,800$20.04M$53.63M5.15%+$33.59M
Elevance Health, Inc.(ELV)69,50085,800+16,300$36.04M$46.49M4.46%+$10.45M
Boston Scientific Corporation(BSX)582,000595,000+13,000$39.86M$45.82M4.40%+$5.96M
Eli Lilly and Company(LLY)54,17547,000-7,175$42.15M$42.55M4.09%+$406.9K
Regeneron Pharmaceuticals, Inc.(REGN)34,30032,000-2,300$33.01M$33.63M3.23%+$619.6K
AbbVie Inc.(ABBV)189,500189,000-500$34.51M$32.42M3.11%-$2.09M
Tenet Healthcare Corporation(THC)380,000229,000-151,000$39.94M$30.46M2.92%-$9.48M
Oscar Health, Inc.CL A(OSCR)1,691,5221,906,611+215,089$25.15M$30.16M2.90%+$5.01M
The Cooper Companies, Inc.(COO)301,000310,000+9,000$30.54M$27.06M2.60%-$3.48M
Intuitive Surgical, Inc.(ISRG)50,50060,500+10,000$20.15M$26.91M2.58%+$6.76M
PROCEPT BioRobotics Corporation(PRCT)487,063440,000-47,063$24.07M$26.88M2.58%+$2.81M
Becton, Dickinson and Company(BDX)116,000113,000-3,000$28.70M$26.41M2.54%-$2.29M
HCA Healthcare, Inc.(HCA)100,00082,000-18,000$33.35M$26.34M2.53%-$7.01M
Vertex Pharmaceuticals Incorporated(VRTX)56,50054,000-2,500$23.62M$25.31M2.43%+$1.69M
The Cigna Group(CI)137,17174,171-63,000$49.82M$24.52M2.35%-$25.30M
Merck & Co., Inc.(MRK)218,500175,000-43,500$28.83M$21.66M2.08%-$7.17M
Alnylam Pharmaceuticals, Inc.(ALNY)42,30085,500+43,200$6.32M$20.78M1.99%+$14.45M
BioMarin Pharmaceutical Inc.(BMRN)237,500251,500+14,000$20.74M$20.71M1.99%-$37.3K
Biogen Inc.(BIIB)56,80084,800+28,000$12.25M$19.66M1.89%+$7.41M
McKesson Corporation(MCK)44,00030,000-14,000$23.62M$17.52M1.68%-$6.10M
Natera, Inc.(NTRA)240,000157,000-83,000$21.95M$17.00M1.63%-$4.95M
Medtronic plcSHS(MDT)325,000208,000-117,000$28.32M$16.37M1.57%-$11.95M
Gilead Sciences, Inc.(GILD)127,000238,500+111,500$9.30M$16.36M1.57%+$7.06M
Abbott Labs185,000145,000-40,000$21.03M$15.07M1.45%-$5.96M
Royalty Pharma plcCL A(RPRX)544,697544,6970$16.54M$14.36M1.38%-$2.18M
Dynavax Technologies Corp1,157,3611,232,361+75,000$14.36M$13.84M1.33%-$523.4K
Align Technology Inc50,00056,500+6,500$16.40M$13.64M1.31%-$2.76M
Thermo Fisher Scientific Inc.(TMO)13,00024,000+11,000$7.56M$13.27M1.27%+$5.72M
DexCom, Inc.(DXCM)138,500117,000-21,500$19.21M$13.27M1.27%-$5.94M
Centene Corporation(CNC)129,000198,482+69,482$10.12M$13.16M1.26%+$3.04M
Alignment Healthcare, Inc.(ALHC)2,022,7361,641,448-381,288$10.03M$12.84M1.23%+$2.80M
Jazz Pharmaceuticals plcSHS USD(JAZZ)146,729114,000-32,729$17.67M$12.17M1.17%-$5.50M
Danaher Corporation(DHR)11,00048,500+37,500$2.75M$12.12M1.16%+$9.37M
Cencora Inc42,50051,500+9,000$10.33M$11.60M1.11%+$1.28M
Cytokinetics, Incorporated(CYTK)197,515197,5150$13.85M$10.70M1.03%-$3.15M
Neurocrine Biosciences, Inc.(NBIX)59,00075,555+16,555$8.14M$10.40M1.00%+$2.26M
Axsome Therapeutics, Inc.(AXSM)143,600127,600-16,000$11.46M$10.27M0.99%-$1.19M
Intra-Cellular Therapies Inc137,500142,000+4,500$9.52M$9.73M0.93%+$210.6K
Insulet Corporation(PODD)34,75046,500+11,750$5.96M$9.38M0.90%+$3.43M
Edwards Lifesciences Corp097,500+97,500$0$9.01M0.86%+$9.01M
Madrigal Pharmaceuticals, Inc.(MDGL)36,50026,500-10,000$9.75M$7.42M0.71%-$2.32M
Iovance Biotherapeutics, Inc.(IOVA)955,000920,000-35,000$14.15M$7.38M0.71%-$6.77M
Charles River Laboratories International, Inc.(CRL)12,70034,000+21,300$3.44M$7.02M0.67%+$3.58M
Insmed Incorporated(INSM)099,513+99,513$0$6.67M0.64%+$6.67M
IQVIA Holdings Inc.(IQV)31,00031,0000$7.84M$6.55M0.63%-$1.28M
Nuvalent Inc87,50082,750-4,750$6.57M$6.28M0.60%-$293.0K
Ionis Pharmaceuticals, Inc.(IONS)0130,000+130,000$0$6.20M0.59%+$6.20M
Endeavour Silver Corp.(EXK)143,000145,000+2,000$9.88M$6.13M0.59%-$3.75M
Stryker Corporation(SYK)8,00018,000+10,000$2.86M$6.12M0.59%+$3.26M
Arvinas, Inc.(ARVN)170,000230,000+60,000$7.02M$6.12M0.59%-$895.0K
Viking Therapeutics, Inc.(VKTX)145,000115,000-30,000$11.89M$6.10M0.59%-$5.79M
Glaukos Corporation(GKOS)27,00050,000+23,000$2.55M$5.92M0.57%+$3.37M
Merus N V090,500+90,500$0$5.35M0.51%+$5.35M
Encompass Health Corporation(EHC)29,00060,000+31,000$2.39M$5.15M0.49%+$2.75M
Syndax Pharmaceuticals, Inc.(SNDX)178,500228,500+50,000$4.25M$4.69M0.45%+$442.8K
BridgeBio Pharma, Inc.(BBIO)104,500184,500+80,000$3.23M$4.67M0.45%+$1.44M
Mirum Pharmaceuticals, Inc.(MIRM)92,250134,250+42,000$2.32M$4.59M0.44%+$2.27M
Janux Therapeutics, Inc.(JANX)104,500106,847+2,347$3.93M$4.48M0.43%+$541.4K
Annexon, Inc.(ANNX)0900,000+900,000$0$4.41M0.42%+$4.41M
Esperion Therapeutics Inc Ne01,975,000+1,975,000$0$4.38M0.42%+$4.38M
Essa Pharma Inc911,820806,054-105,766$7.74M$4.24M0.41%-$3.50M
Xencor, Inc.(XNCR)218,750218,7500$4.84M$4.14M0.40%-$700.0K
Penumbra, Inc.(PEN)46,00023,000-23,000$10.27M$4.14M0.40%-$6.13M
TG Therapeutics, Inc.(TGTX)123,500213,500+90,000$1.88M$3.80M0.36%+$1.92M
Nurix Therapeutics, Inc.(NRIX)0174,393+174,393$0$3.64M0.35%+$3.64M
Alkermes plcSHS(ALKS)110,000150,000+40,000$2.98M$3.62M0.35%+$637.3K
Krystal Biotech, Inc.(KRYS)19,00019,0000$3.38M$3.49M0.33%+$108.5K
Immunovant, Inc.(IMVT)125,500130,500+5,000$4.05M$3.45M0.33%-$609.7K
Kura Oncology, Inc.(KURA)166,526166,5260$3.55M$3.43M0.33%-$123.2K
STAAR Surgical Company(STAA)065,000+65,000$0$3.09M0.30%+$3.09M
Acadia Healthcare Company, Inc.(ACHC)12,62439,824+27,200$1.00M$2.69M0.26%+$1.69M
Inspire Medical Systems, Inc.(INSP)42,00017,000-25,000$9.02M$2.28M0.22%-$6.75M
Apellis Pharmaceuticals Inc
COM
178,39555,395-123,000$10.49M$2.12M0.20%-$8.36M
Molina Healthcare, Inc.(MOH)07,000+7,000$0$2.08M0.20%+$2.08M
TransMedics Group, Inc.(TMDX)013,500+13,500$0$2.03M0.20%+$2.03M
Privia Health Group, Inc.(PRVA)114,000114,0000$2.23M$1.98M0.19%-$251.9K
Immunocore Holdings plcADS(IMCR)79,77858,278-21,500$5.19M$1.98M0.19%-$3.21M
IDEAYA Biosciences, Inc.(IDYA)053,500+53,500$0$1.88M0.18%+$1.88M
Revance Therapeutics Inc701,707701,7070$3.45M$1.80M0.17%-$1.65M
INmune Bio Inc.(INMB)178,284178,2840$2.09M$1.57M0.15%-$522.4K
Relay Therapeutics, Inc.(RLAY)230,000230,0000$1.91M$1.50M0.14%-$409.4K
Bio-Techne Corporation(TECH)16,00020,000+4,000$1.13M$1.43M0.14%+$306.8K
Xenon Pharmaceuticals Inc.(XENE)035,000+35,000$0$1.36M0.13%+$1.36M
Igm Biosciences Inc195,000195,0000$1.88M$1.34M0.13%-$542.1K
Amgen Inc.(AMGN)4,2504,2500$1.21M$1.33M0.13%+$119.6K
Pliant Therapeutics, Inc.(PLRX)145,250120,250-25,000$2.16M$1.29M0.12%-$871.5K
Avantor, Inc.(AVTR)171,00060,000-111,000$4.37M$1.27M0.12%-$3.10M
Repligen Corporation(RGEN)5,00010,000+5,000$919.6K$1.26M0.12%+$341.0K
Medpace Holdings, Inc.(MEDP)02,500+2,500$0$1.03M0.10%+$1.03M
Inari Med Inc56,42020,000-36,420$2.71M$963.0K0.09%-$1.74M
Evolent Health, Inc.CL A(EVH)050,000+50,000$0$956.0K0.09%+$956.0K
Augmedix Inc800,0001,000,000+200,000$3.27M$880.0K0.08%-$2.39M
Bruker Corporation(BRKR)20,0006,000-14,000$1.88M$382.9K0.04%-$1.50M
Alpine Immune Sciences Inc85,5000-85,500$3.39M$0—-$3.39M
Intellia Therapeutics, Inc.(NTLA)48,0000-48,000$1.32M$0—-$1.32M
NovoCure Limited(NVCR)495,3070-495,307$7.74M$0—-$7.74M
Shockwave Medical Inc64,0000-64,000$20.84M$0—-$20.84M
Zimmer Biomet Holdings, Inc.(ZBH)67,5000-67,500$8.91M$0—-$8.91M
Page 1 of 1
Rhenman & Partners Asset Management AB — 13F Holdings — Q2 2024 | TickerTrail